معرفی
Paul McKeigue is Professor of Genetic Epidemiology and Statistical Genetics at the Centre for Population Health Sciences, Usher Institute, College of Medicine and Veterinary Medicine, The University of Edinburgh. He holds a Chair in his discipline and actively supervises doctoral candidates while leading major research initiatives.
His research centers on genetic epidemiology and statistical genetics, with primary focus on diabetes (type 1, type 2, and maturity-onset variants), cardiovascular disease, and rheumatoid arthritis. He pioneers genome-wide aggregated trans-effects analysis to identify core disease genes, integrating genomic data with clinical outcomes through innovative statistical frameworks.
Recent publications reveal a distinct trajectory toward translational applications, particularly in autoimmune disease mechanisms and diabetes complications. His work bridges genetic discovery with clinical epidemiology, exemplified by studies on post-infection cardiovascular risks in diabetic populations and core gene identification through proteomic integration.
McKeigue leads multiple funded projects including Diabetes UK's Real World Pharmacoepidemiology initiative (2025-2028), Joslin Diabetes Center's cardiovascular risk stratification study (2024-2025), and Iqvia Ltd's EXCEED safety study (2021-2027). He is integral to the Scottish Diabetes Research Network Epidemiology Group, driving international collaborations that leverage electronic health records and artificial intelligence.
